Barbados vs Canada: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Barbados
85.0%
in 2025
Canada
85.0%
in 2025
Barbados rank
96th
Canada rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Barbados
- Canada
How they compare
Barbados currently reports 85.0% against 85.0% in Canada, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Canada ahead.
Barbados ranks 96th and Canada ranks 96th of 194 countries.
Across the 3 decades both report, Barbados averaged higher in 2 and Canada in 1.
Head to head by decade
| Decade | Barbados | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.5% | 46.0% | 8.5% | Canada |
| 2010s | 88.4% | 76.1% | 12.3% | Barbados |
| 2020s | 85.5% | 84.7% | 0.8% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Barbados or Canada?
- Barbados, at 85.0% against 85.0% in Canada as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Barbados and Canada?
- 0.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Canada?
- 18 years are reported by both, from 2008 to 2025.
- How do Barbados and Canada rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Barbados ranks 96th and Canada ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.